Immunization, Pol3 in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)
Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD): Immunization, Pol3 was 83.6% in 2024. ▲ Rising
Immunization, Pol3 in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD), 1980–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of one-year-old children.
Analysis
In 2024, immunization, pol3 in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) stood at 83.6%.
Compared with earlier readings it is up 0.5% on the previous year and up 5.5% over ten years.
Over the whole period, immunization, pol3 in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) peaked at 84.4% in 2019 and was at its lowest, 19.5%, in 1980.
Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) ranks 27th of 43 groups on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 45 years of available data.
Immunization, Pol3 in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD), year by year
| Year | % of one-year-old children | Change |
|---|---|---|
| 1980 | 19.5% | — |
| 1981 | 24.4% | +25.4% |
| 1982 | 31.9% | +30.6% |
| 1983 | 30.5% | -4.4% |
| 1984 | 38.1% | +24.8% |
| 1985 | 50.9% | +33.8% |
| 1986 | 55.4% | +8.7% |
| 1987 | 56.2% | +1.4% |
| 1988 | 65.0% | +15.8% |
| 1989 | 66.8% | +2.7% |
| 1990 | 73.1% | +9.4% |
| 1991 | 68.7% | -5.9% |
| 1992 | 67.2% | -2.2% |
| 1993 | 64.7% | -3.7% |
| 1994 | 62.8% | -3.0% |
| 1995 | 70.8% | +12.9% |
| 1996 | 67.4% | -4.9% |
| 1997 | 69.3% | +2.9% |
| 1998 | 72.7% | +4.9% |
| 1999 | 73.8% | +1.6% |
| 2000 | 74.4% | +0.8% |
| 2001 | 75.5% | +1.4% |
| 2002 | 75.0% | -0.5% |
| 2003 | 75.8% | +1.0% |
| 2004 | 77.2% | +1.9% |
| 2005 | 76.8% | -0.5% |
| 2006 | 75.2% | -2.2% |
| 2007 | 74.7% | -0.7% |
| 2008 | 74.1% | -0.7% |
| 2009 | 74.1% | -0.0% |
| 2010 | 74.1% | +0.0% |
| 2011 | 77.5% | +4.5% |
| 2012 | 76.6% | -1.1% |
| 2013 | 78.0% | +1.8% |
| 2014 | 79.3% | +1.7% |
| 2015 | 79.8% | +0.7% |
| 2016 | 81.5% | +2.1% |
| 2017 | 81.4% | -0.1% |
| 2018 | 80.5% | -1.1% |
| 2019 | 84.4% | +4.8% |
| 2020 | 82.2% | -2.6% |
| 2021 | 81.2% | -1.1% |
| 2022 | 83.3% | +2.5% |
| 2023 | 83.2% | -0.1% |
| 2024 | 83.6% | +0.5% |
Biggest year-on-year movements
Years where Immunization, Pol3 in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 1985 | +33.8% | 38.1% | 50.9% |
| 1982 | +30.6% | 24.4% | 31.9% |
| 1981 | +25.4% | 19.5% | 24.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1980s | 43.9% | 19.5% | 66.8% | 10 |
| 1990s | 69.1% | 62.8% | 73.8% | 10 |
| 2000s | 75.3% | 74.1% | 77.2% | 10 |
| 2010s | 79.3% | 74.1% | 84.4% | 10 |
| 2020s | 82.7% | 81.2% | 83.6% | 5 |
Countries ranked near Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)
- 29 Albania 97.0% compare
- 29 Bangladesh 97.0% compare
- 29 China 97.0% compare
- 29 Egypt 97.0% compare
- 29 South Korea 97.0% compare
- 29 Latvia 97.0% compare
- 29 Malta 97.0% compare
- 29 Nauru 97.0% compare
- 29 Nepal 97.0% compare
- 29 Norway 97.0% compare
- 29 Palau 97.0% compare
- 29 Russia 97.0% compare
- 29 Saudi Arabia 97.0% compare
- 29 Singapore 97.0% compare
- 29 Sri Lanka 97.0% compare
- 29 Saint Kitts and Nevis 97.0% compare
- 29 Tajikistan 97.0% compare
More health data for Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)
- Population ages 35-39, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, male, annual growth rate 3.1 % change on previous year (2025)
- Population ages 40-44, female, per capita 0.0305 units per person (2025)
- Population ages 40-44, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, female, annual growth rate 3.2 % change on previous year (2025)
- Population ages 35-39, male, per capita 0.0351 units per person (2025)
- Population ages 35-39, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, male, annual growth rate 1.48 % change on previous year (2025)
- Population ages 35-39, female, per capita 0.0341 units per person (2025)
- Population ages 30-34, female, annual growth rate 0.471 % change on previous year (2025)
All data for Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) →
Frequently asked questions
- What is immunization, pol3 in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)?
- Immunization, pol3 in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) was 83.6% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, pol3 recorded in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)?
- The highest recorded value was 84.4% in 2019.
- What is the lowest immunization, pol3 recorded in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)?
- The lowest recorded value was 19.5% in 1980.
- How does Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) rank for immunization, pol3?
- Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) ranks 27th out of 43 groups with data for 2024.
- Is immunization, pol3 rising or falling in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)?
- Over the last ten years it is up 5.5%. The long-run trend across the full record is rising.
- Where does this Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Pol3 (% of one-year-old children). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 45 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization rate, polio, is the percentage of children ages 12-23 months who received polio vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.